Nationwide coordination for DOT return-to-duty testing after a driver has completed the required Substance Abuse Professional (SAP) process and is ready to complete the applicable return-to-duty drug and/or alcohol test.
The driver must complete the SAP evaluation and prescribed education and/or treatment requirements before proceeding to the applicable return-to-duty test.
Purchase sends you directly to checkout. DOT return-to-duty drug testing requires a directly observed collection.
The driver must complete the required steps before returning to DOT safety-sensitive work. Follow-up testing takes place after the return-to-duty requirement has been successfully completed.
A DOT drug or alcohol program violation removes the driver from safety-sensitive functions and begins the required SAP return-to-duty process.
The driver completes the SAP evaluation and any prescribed education and/or treatment. After successful compliance, the driver may proceed to the applicable return-to-duty test.
The employer directs the required return-to-duty drug and/or alcohol test. The applicable testing requirement must be successfully satisfied before the driver resumes safety-sensitive duties.
The SAP establishes a written follow-up testing plan. After the driver returns to safety-sensitive work, the employer carries out that plan using the required unannounced follow-up tests.
DOT return-to-duty testing is a required step for an employee seeking to resume safety-sensitive work after completing the SAP requirements following a DOT drug or alcohol violation.
A return-to-duty test is not the same as a standard pre-employment, random, or company-policy drug test. The test must be identified using the proper return-to-duty reason.
The driver must first complete the SAP process and prescribed requirements before proceeding to the return-to-duty test.
The employer must not allow the employee to resume DOT safety-sensitive functions until the applicable return-to-duty testing requirement has been successfully completed.
A return-to-duty drug test uses a different collection procedure than a standard DOT drug test because federal DOT rules require the return-to-duty drug collection to be conducted under direct observation.
Under 49 CFR §40.67, the employer must direct a collection under direct observation when the drug-test reason is return-to-duty. The collection site therefore must perform the additional DOT observed-collection procedures.
Because of this additional collection requirement, CDL Inquiry's DOT return-to-duty drug testing service is $95, compared with $65 for a standard DOT drug test.
The $95 amount is CDL Inquiry's service price. It is not a government-established DOT or FMCSA fee.
The applicable return-to-duty testing requirement must be successfully satisfied before the driver may resume DOT safety-sensitive functions.
The employee must have a verified negative drug test result before resuming the performance of safety-sensitive duties.
When an alcohol return-to-duty test applies, the employee must have an alcohol concentration of less than 0.02 before resuming safety-sensitive duties.
Return-to-duty testing is part of an employer-controlled DOT compliance process. It is not simply a regular test that a driver orders independently and then uses as proof of completing the federal return-to-duty process.
For an FMCSA-regulated CDL driver with a current or prospective Part 382 employer, the employer directs the driver to complete the return-to-duty test and handles the applicable Clearinghouse responsibilities.
Owner-operators are required to use a designated C/TPA for applicable Clearinghouse return-to-duty responsibilities. FMCSA also provides a limited C/TPA pathway for certain drivers without a current or prospective employer.
Once the driver has successfully completed the required SAP process and is ready for return-to-duty testing, the employer or appropriate C/TPA should coordinate the correct test before sending the driver to the collection site.
Confirm that the driver has completed the prescribed SAP education and/or treatment requirements and may proceed with return-to-duty testing.
Provide the information needed to identify the proper return-to-duty test and coordinate the collection location.
CDL Inquiry prepares the testing authorization and collection-site instructions so the test is conducted using the correct return-to-duty reason.
If the driver has successfully completed the required SAP process and is ready for return-to-duty testing, place the order and CDL Inquiry can coordinate the testing authorization.
Schedule Return-to-Duty TestingA successful return-to-duty test is not the end of the DOT compliance process. Once the driver returns to safety-sensitive duties, the employer must carry out the SAP's follow-up testing plan.
The applicable negative drug result and/or alcohol result below 0.02 must be obtained before the driver returns to safety-sensitive functions.
Once the regulatory conditions have been satisfied, the employer decides whether to return or hire the employee into a safety-sensitive position.
After the driver returns to safety-sensitive work, the employer must carry out the SAP's written follow-up testing plan using unannounced follow-up tests.
Both are part of the DOT return-to-duty process, but they occur at different stages and serve different purposes.
| Testing Type | When It Occurs | Purpose | Drug Test Observation |
|---|---|---|---|
| Return-to-Duty Test | After successful SAP compliance and before returning to safety-sensitive duties. | Establishes that the applicable return-to-duty testing condition has been met before the employee resumes safety-sensitive work. | Direct observation required. |
| Follow-Up Test | During safety-sensitive duty after the employee returns to work. | Conducted according to the SAP's written follow-up testing plan. | Direct observation required for follow-up drug tests. |
The driver must first complete the required SAP process, including any prescribed education and/or treatment, before proceeding with the return-to-duty test.
Yes. DOT regulations require a drug collection to be conducted under direct observation when the reason for testing is return-to-duty.
A return-to-duty drug test requires the additional DOT directly observed collection process. CDL Inquiry's return-to-duty drug testing service is therefore $95 compared with $65 for a standard DOT drug test. These are CDL Inquiry service prices, not government fees.
The employee must have a verified negative drug test result before resuming safety-sensitive duties.
When an alcohol return-to-duty test applies, the employee must have an alcohol concentration of less than 0.02 before resuming safety-sensitive duties.
For an FMCSA-regulated driver with a current or prospective Part 382 employer, the employer directs the driver to the return-to-duty test. FMCSA provides a separate limited C/TPA pathway for certain drivers without a current or prospective employer.
No. Successfully satisfying the DOT return-to-duty requirements does not require an employer to reinstate or hire the employee. The employer makes that personnel decision.
Once the applicable return-to-duty requirements are satisfied and the employee returns to safety-sensitive duties, the employer must carry out the SAP's written follow-up testing plan.
The Substance Abuse Professional establishes the written follow-up testing plan after determining that the employee has successfully complied with the SAP's education and/or treatment recommendations. The employer then carries out the required unannounced follow-up testing after the employee returns to safety-sensitive duty.
No. Return-to-duty testing is a specific DOT testing reason connected to a prior DOT drug or alcohol violation and the SAP process. A routine pre-employment test does not replace a required return-to-duty test.
Employers and drivers should use current federal regulations, FMCSA guidance, and the applicable SAP documentation as the controlling sources for return-to-duty requirements.
Once the driver has successfully completed the SAP requirements and is ready for return-to-duty testing, CDL Inquiry can coordinate the appropriate testing location and prepare the testing authorization.